Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature Update

by Stine Dam Henriksen, Ole Thorlacius-Ussing
Published 2021-04-01

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma

by Benjamin Emil Stubbe, Benjamin Emil Stubbe, Benjamin Emil Stubbe, Anders Christian Larsen, Anders Christian Larsen, Poul Henning Madsen, Poul Henning Madsen, Henrik Bygum Krarup, Henrik Bygum Krarup, Inge Søkilde Pedersen, Inge Søkilde Pedersen, Inge Søkilde Pedersen, Søren Lundbye-Christensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Astrid Zedlitz Johansen, Ole Thorlacius-Ussing, Ole Thorlacius-Ussing, Ole Thorlacius-Ussing, Julia Sidenius Johansen, Julia Sidenius Johansen, Julia Sidenius Johansen, Stine Dam Henriksen, Stine Dam Henriksen, Stine Dam Henriksen
Published 2023-06-01

Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma

by Benjamin Emil Stubbe, Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Henrik Bygum Krarup, Inge Søkilde Pedersen, Martin Nygård Johansen, Ole Thorlacius-Ussing
Published 2021-11-01